Show simple item record

dc.contributor.authorMitropanopoulos, Meg
dc.date.accessioned2011-10-27T23:12:05Z
dc.date.available2011-10-27T23:12:05Z
dc.date.issued2011-03
dc.identifier.urihttp://hdl.handle.net/10150/170534
dc.descriptionA Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.en
dc.description.abstractHepatocellular carcinoma (HCC) is the fifth most common solid tumor worldwide. There are 626,000 new cases per year of primary liver cancer worldwide, most of which are HCC. Over 1,000,000 people die of HCC per year, making HCC the third most frequent cause of cancer deaths worldwide1. Major etiologic factors associated with HCC include chronic HBV and HCV infection, chronic alcoholism, non-alcoholic steatohepatitis, and aflatoxin exposure. The standard treatment for HCC is surgical resection, however on presentation many patients have progressed to the point where such treatment is not an option, and are placed on liver transplant lists. Palliative treatment modalities are often used in the interim, including trans-arterial chemoembolization (TACE), radiofrequency ablation (RFA), or systemic chemotherapy. In this study over 200 patients who received either Therasphere or Sirsphere (TACE methods), or RFA treatment for unresectable HCC were catalogued in a relational database allowing for analysis of treatment outcomes and treatment comparisons. A Microsoft Access database was created to store data such as patient demographics, disease details, adverse events, patient lab values, treatment details, and pre- and post-lesion measurements. This database is currently in use by the department of Interventional Radiology at Banner Good Samaritan Medical Center.
dc.language.isoen_USen
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the College of Medicine - Phoenix, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.subject.meshCarcinoma, Hepatocellularen
dc.subject.meshDatabases, factualen
dc.subject.meshDisease managementen
dc.titleDevelopment of a Database for Storage and Analysis of Factors Affecting Treatment of Hepatocellular Carcinomaen_US
dc.typetext; Electronic Thesisen
dc.contributor.departmentThe University of Arizona College of Medicine - Phoenixen
dc.description.collectioninformationThis item is part of the College of Medicine - Phoenix Scholarly Projects 2011 collection. For more information, contact the Phoenix Biomedical Campus Library at pbc-library@email.arizona.edu.en_US
dc.contributor.mentorWood, Daviden
refterms.dateFOA2018-06-26T04:02:48Z
html.description.abstractHepatocellular carcinoma (HCC) is the fifth most common solid tumor worldwide. There are 626,000 new cases per year of primary liver cancer worldwide, most of which are HCC. Over 1,000,000 people die of HCC per year, making HCC the third most frequent cause of cancer deaths worldwide1. Major etiologic factors associated with HCC include chronic HBV and HCV infection, chronic alcoholism, non-alcoholic steatohepatitis, and aflatoxin exposure. The standard treatment for HCC is surgical resection, however on presentation many patients have progressed to the point where such treatment is not an option, and are placed on liver transplant lists. Palliative treatment modalities are often used in the interim, including trans-arterial chemoembolization (TACE), radiofrequency ablation (RFA), or systemic chemotherapy. In this study over 200 patients who received either Therasphere or Sirsphere (TACE methods), or RFA treatment for unresectable HCC were catalogued in a relational database allowing for analysis of treatment outcomes and treatment comparisons. A Microsoft Access database was created to store data such as patient demographics, disease details, adverse events, patient lab values, treatment details, and pre- and post-lesion measurements. This database is currently in use by the department of Interventional Radiology at Banner Good Samaritan Medical Center.


Files in this item

Thumbnail
Name:
Mitropanopoulos_Poster.pdf
Size:
2.061Mb
Format:
PDF
Description:
Poster
Thumbnail
Name:
Mitropanopoulos_Thesis.pdf
Size:
3.619Mb
Format:
PDF
Description:
Thesis and Poster

This item appears in the following Collection(s)

Show simple item record